IMMUNOHISTOCHEMISTRY - MARKERS OF NERVOUS SYSTEM CARCINOMAS - ANVISA Registration 80000230041

Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - MARKERS OF NERVOUS SYSTEM CARCINOMAS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80000230041 and manufactured by AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.. The registration is held by AGILENT TECHNOLOGIES BRASIL LTDA with validity until Mar 05, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 3 companies making the same product including CELL MARQUE CORPORATION, VENTANA MEDICAL SYSTEM, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.